This is the first book to establish guidelines and to assist prescribers and therapists in withdrawing their patients from psychiatric drugs, including those patients with long-term exposure to antipsychotic drugs, benzodiazepines, stimulants, antidepressants, and mood stabilizers. It describes a method developed by the author throughout years of clinical experience, consultations with experienced colleagues, and scientific research. Based on a person-centered collaborative approach, with patients as partners, this method builds on a cooperative and empathic team effort involving prescribers, therapists, patients, and their families or support network.
The author, known for such books as Talking Back to Prozac, Toxic Psychiatry, and Medication Madness, is a lifelong reformer and scientist in mental health whose work has brought about significant change in psychiatric practice. This book provides critical information about when to consider psychiatric drug reduction or withdrawal, and how to accomplish it as safely, expeditiously, and comfortably as possible. It offers the theoretical framework underlying this approach along with extensive scientific information, practical advice, and illustrative case studies that will assist practitioners in multiple ways, including in how to:
- Recognize common and sometimes overlooked adverse drug effects that may require withdrawal
- Treat emergencies during drug therapy and during withdrawal
- Determine the first drugs to withdraw during multi-drug therapy
- Distinguish between withdrawal reactions, newly occurring emotional problems, and recurrence of premedication issues
- Estimate the length of withdrawal
قائمة المحتويات
‘
Foreword
Acknowledgments
1. A Person-Centered Collaborative Method for Psychiatric Drug Withdrawal
Part I: Reasons to Consider Psychiatric Drug Withdrawal or Dose Reduction
2. Cautions in Assessing the Risks Associated with Psychiatric Drugs
3. Chronic Brain Impairment (CBI): A Reason to Withdraw Patients from Long-Term Exposure to All Classes of Psychiatric Medication
4. Antipsychotic Drugs
5. Antidepressant Drugs
6. Stimulant Drugs
7. Benzodiazepine and Other Sedative Drugs
8. Lithium and Other Mood Stabilizers
9. Medication Spellbinding (Intoxication Anosognosia)
Part II: The Drug Withdrawal Process
10. Special Withdrawal Problems with Each Class of Psychiatric Drug
11. The Initiation Evaluation: Creating a Medication History while Building Trust and Hope
12. Developing Team Collaboration
13. Psychotherapy during Medication Withdrawal
14. Handling Emotional Crises
15. Techniques for Beginning Medication Withdrawal
16. Techniques for Managing and Completing Withdrawal Long-Term Withdrawal in Adults
17. Techniques for Managing and Completing Withdrawal in Children
18. Lifestyle Changes and Personal Growth
19. Conclusion
Appendices
A. Psychiatric Drugs by Category
B. Additional Scientific Resources: Books, Journals and Internet
عن المؤلف
Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books.